ReSurfX::vysen 2.0 our is a rapidly evolving enterprise-grade, cloud-based, integrative analytics platform leveraging our novel and powerful 'Adaptive Hypersurface Technology (AHT)' to provide intelligence in variety of data-intensive problems and is focused on the life science and healthcare sectors. Leveraging AHT, ReSurfX::vysen helps organizations gain remarkable improvements in levels of accuracy, novel insights, and automation of knowledge extraction significantly improving innovation and ROI in data-analytics initiatives. A prime goal of ReSurfX is to disrupt the status quo in data and technology-intensive enterprises by incorporating novel data-source agnostic solutions through innovations outside the mainstream of standard analytics frameworks to overcome problems common to most analytics concepts.
vysen (aka ReSurfX::vysen) is so named at it is intended to 'wisen' experts in your enterprises to significantly improve innovation, outcomes and ROI. Learn about the origin of our name - ReSurfX.
We are revolutionizing healthcare through novel and effective data utilization strategies to combine large scale measurement technologies (e.g., omics data) and data from healthcare settings (e.g., EHR). vysen is one component of our product portfolio to deliver data-analytics to significantly improve life sciences discovery, drug development, healthcare outcomes and efficient delivery of high cost healthcare products
Technology and Product
Adaptive Hypersurface Technology (AHT) is a novel data-analytics concept based on adaptively identifying many combinations of input parameters that can determine the same outcome of interest. This novel and powerful comparative analytics approach leads to robust, sensitive and accurate outcomes with inherent personalization. In customer data initiatives and on widely studied large datasets used as benchmark AHT yielded unprecedented levels of accuracy compared to other analytic approaches.
The current product, ReSurfX::vysen, leverages the superior advantages of AHT to provide 'best in class' gene expression analytics from sequencing and microarray, and ability to predict triggers and outcomes based on total system responses (SyRTOP) and has repository scale processing capabilities with unique product structure and integration advantages. As our results show that existing back-end databases used for gleaning knowledge (Knowledge Repositories) have over 30% errors, we provide Big Data solutions to generate ACCURATE custom knowledge repositories from proprietary data of customers.
vysen 2.0 adopts an attractive tiered pricing model that aligns cost for customers with their volume of data usage. We also offer a FREE TRIAL version to experience the product advantages and features.
Hybrid Solution Portfolio
We deploy a dual strategy to big data problems both through technology redesign solutions to remove fundamental errors at data generation step and decision analytic products for efficient downstream outcomes intelligence. Our products and solutions offer tremendous advantages and applications in areas of Personalized Medicine, Clinical Trials, Drug Discovery and Development, Patient Care Decision and more.
ReSurfX::vysen 2.0 is just one component of our interlinked product line providing end-to-end value to life science and healthcare enterprises:
- Advance Outcomes Alert System (AOAS) for clinical trials, newer business models for pharmaceutical product sales and quantitative support for evidence-based medicine.
- Getting superior data to flow through enterprise workflows facilitating automated knowledge extraction, novel insights, and more efficient discovery and downstream business operations.
- Redesign of measurement systems that generate large volumes of data or of systems used in large volumes (e.g., sequencing scanners, physical and e-diagnostics) at both the sensor and component levels. ReSurfX sensor/component level technology redesign solutions improve the quality of data while simplifying data usage.
Click here to learn more about the vysen product
ReSurfX continues to garner recognition as a promising company bringing unique leading edge
value to the healthcare and life sciences industry.
We have been recognized with numerous accolades which include recognition as:
- One of '20 Most Promising Data Analytics Vendors 2017' by CIOReview magazine.
- An 'emerging company defining the next generation of personalized medicine platforms and technologies' by the Personalized Medicine World Congress (PMWC).
## ReSurfX, ReSurfX::vysen, SyRTOP, Adaptive Hypersurface Technology. Advance Outcomes Alert System are trademarks of ReSurfX Inc.